Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 8 Results

Title
Intervention Indication Therapeutic Area Year Actions
Axalimogene Filolisbac for Cervical Cancer – Beyond First Line Treatment Axalimogene filolisbac (ADXS11-001) Cervical cancer Female Reproductive Cancer 2018 View  |  Download
Bintrafusp alfa for advanced, unresectable cervical cancer Bintrafusp alfa (M7824; GSK4045154) Cervical cancer Female Reproductive Cancer 2021 View  |  Download
Cemiplimab for recurrent, persistent or metastatic cervical cancer – second line Cemiplimab (Libtayo; REGN2810) Cervical cancer Female Reproductive Cancer 2020 View  |  Download
Durvalumab add-on therapy for previously untreated locally advanced cervical cancer Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) Cervical cancer Female Reproductive Cancer 2022 View  |  Download
LN-145 for recurrent, metastatic or persistent cervical carcinoma LN-145 Cervical cancer Female Reproductive Cancer 2020 View  |  Download
Pembrolizumab inaddition to chemotherapy for persistent, recurrent or metastatic cervical cancer – first line Pembrolizumab (Keytruda; MK-3475) Cervical cancer Female Reproductive Cancer 2020 View  |  Download
Pembrolizumab with chemoradiotherapy for treating high-risk locally advanced cervical cancer Chemoradiotherapy , Pembrolizumab (Keytruda; MK-3475) Cervical cancer Female Reproductive Cancer 2022 View  |  Download
Tisotumab vedotin for recurrent or metastatic cervical cancer Tisotumab vedotin (HuMax-TF-ADC) Cervical cancer Female Reproductive Cancer 2019 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications